{
  "content": "Diagnosis:\nLocally advanced pancreatic adenocarcinoma, T3N0M0\nNTRK fusion positive\n\nPrevious treatment:\nWhipple's procedure March 2024\nAdjuvant FOLFIRINOX commenced April 2024\n\nCurrent medications:\nEntrectinib 600mg daily\nPancreatic enzyme replacement\nMetformin for chemotherapy-induced diabetes\n\nCurrent situation:\nCycle 3 of adjuvant FOLFIRINOX completed\n\nI reviewed [redacted name] today in the pancreatic oncology clinic. She has completed cycle 3 of adjuvant FOLFIRINOX with good tolerance. Her main side effect has been grade 1 peripheral neuropathy affecting fingertips only. Blood sugar control has improved on metformin. Performance status remains 0. CT scan performed last week shows no evidence of recurrent disease. Blood tests including CA19-9 are within normal range. The plan is to proceed with cycle 4 chemotherapy today and review again in three weeks.",
  "output": {
    "primary_cancer": {
      "site": "pancreas",
      "year": 2024,
      "month": 3,
      "metastases": "",
      "tnm_stage": "T3N0M0",
      "histopathology_status": "adenocarcinoma",
      "biomarker_status": "NTRK fusion positive",
      "cancer_timeline": [
        {
          "type": "treatment_surgery",
          "value": "Whipple's procedure",
          "year": 2024,
          "month": 3
        },
        {
          "type": "treatment_systemic_start",
          "value": "Started adjuvant FOLFIRINOX",
          "year": 2024,
          "month": 4
        },
        {
          "type": "laboratory_finding",
          "value": "CA19-9 within normal range",
          "year": 2024,
          "month": null
        },
        {
          "type": "anatomical_finding",
          "value": "CT scan shows no evidence of recurrent disease",
          "year": 2024,
          "month": null
        }
      ]
    },
    "patient_facts": [
      {
        "type": "performance_status",
        "value": "PS 0"
      },
      {
        "type": "comorbidity",
        "value": "Chemotherapy-induced diabetes managed with metformin"
      },
      {
        "type": "current_symptom",
        "value": "Grade 1 peripheral neuropathy affecting fingertips"
      }
    ],
    "status_updates": [
      {
        "type": "clinical_summary",
        "value": "Locally advanced pancreatic adenocarcinoma post Whipple's procedure, currently receiving adjuvant FOLFIRINOX with good tolerance"
      },
      {
        "type": "latest_treatment_toxicity",
        "value": "Grade 1 peripheral neuropathy affecting fingertips only"
      },
      {
        "type": "update_to_treatment",
        "value": "Continuing with cycle 4 FOLFIRINOX"
      },
      {
        "type": "follow_up_referral",
        "value": "Review in three weeks"
      }
    ]
  }
}